News
Important Only
Other
North American insurance stocks rose 4% last week but trailed broader market
By Michael LoneyApril 14 - (The Insurer) - The North American insurance composite compiled by Stonybrook Capital and Weild & Co rose 4.0% last week, trailing most broad market indices.The S&P 500 finished up 5.7% for the week, while the Nasdaq 100 was up 7.4%. In contrast, the Russell 2000 S...Reuters
Mon, Apr 14
Other
Healthy Choice Wellness Announces Same-Store Sales Growth As Part Of Its Record First Quarter 2025 Sales And Gross Profit Performance
April 14 (Reuters) - Healthy Choice Wellness Corp HCWC.A:HEALTHY CHOICE WELLNESS CORP. ANNOUNCES SAME-STORE SALES GROWTH AS PART OF ITS RECORD FIRST QUARTER 2025 SALES AND GROSS PROFIT PERFORMANCEHEALTHY CHOICE WELLNESS CORP - SAME STORE SALES INCREASE 3% IN Q1 2025Reuters
Mon, Apr 14
Other
Neonc Technologies Holdings Expects Full Enrollment In Promising Phase 2A Trial Of Neo100-01 For Malignant Gliomas In September
April 14 (Reuters) - Neonc Technologies Holdings Inc NTHI.O:NEONC TECHNOLOGIES HOLDINGS, INC. EXPECTS FULL ENROLLMENT IN PROMISING PHASE 2A TRIAL OF NEO100-01 FOR MALIGNANT GLIOMAS IN SEPTEMBERReuters
Mon, Apr 14
Other
Florida startup Mangrove completes first reinsurance purchase
By Mia MacGregorApril 14 - (The Insurer) - Florida startup Mangrove Property Insurance Company has completed its first reinsurance purchase, securing coverage for its operations through June 1, 2025, from carriers rated A or higher by AM Best. The company, which holds a financial stability rating of...Reuters
Mon, Apr 14
Other
Longevity Health Holdings Announces Execution Of Merger Agreement With 20/20 Biolabs
April 14 (Reuters) - Longevity Health Holdings Inc XAGE.O:LONGEVITY HEALTH HOLDINGS ANNOUNCES EXECUTION OF MERGER AGREEMENT WITH 20/20 BIOLABSLONGEVITY HEALTH HOLDINGS INC - COMBINED COMPANY TO TRADE ON NASDAQ UNDER SYMBOL 'XAGE'LONGEVITY HEALTH HOLDINGS INC - POST-CLOSING EQUITY VALUATION ...Reuters
Mon, Apr 14
Other
Kandi And Cbak Announce Strategic Partnership To Launch U.S. Lithium Battery Facilities In Phases
April 14 (Reuters) - Kandi Technologies Group Inc K40.F:KANDI AND CBAK ANNOUNCE STRATEGIC PARTNERSHIP TO LAUNCH U.S. LITHIUM BATTERY FACILITIES IN PHASESKANDI TECHNOLOGIES GROUP INC - CBAK TO OWN 90% EQUITY IN CELL MANUFACTURING PLANTKANDI TECHNOLOGIES GROUP INC - TO OWN 90% EQUITY IN PACK ASSEMBLY ...Reuters
Mon, Apr 14
Stocks
Certara rises after Q1 preliminary results, share repurchase program
** Shares of drug development software provider Certara CERT.O rise 7.8% to $13.91** Co expects prelim Q1 revenue of $106 million, above analysts' average estimate of $104.4 million as per data compiled by LSEG ** CERT expects 2025 revenue in the range of $415 million to $425 million, analysts&#...Reuters
Mon, Apr 14
Other
Inhibikase Therapeutics Announces Appointment Of David Mcintyre As CFO
April 14 (Reuters) - Inhibikase Therapeutics Inc IKT.O:INHIBIKASE THERAPEUTICS ANNOUNCES APPOINTMENT OF DAVID MCINTYRE AS CHIEF FINANCIAL OFFICERINHIBIKASE THERAPEUTICS INC - APPOINTMENT OF DAVID MCINTYRE AS CHIEF FINANCIAL OFFICER, EFFECTIVE APRIL 14, 2025Reuters
Mon, Apr 14
Commodities
Mali farmers get $160,000 payouts after yields hit by drought and flooding
By Henry GaleApril 14 - (The Insurer) - More than 7,000 farmers in Mali have received payouts totalling $160,000 under a parametric insurance pilot scheme, agricultural insurtech Pula said in a LinkedIn post on Saturday.The payments to 7,452 farmers affected by lower yields will help them reinvest i...Reuters
Mon, Apr 14
Other
Western Uranium & Vanadium Announces Ore Purchase Agreement
April 14 (Reuters) - Western Uranium & Vanadium Corp WUC.CD:WESTERN URANIUM & VANADIUM CORP. ANNOUNCES ORE PURCHASE AGREEMENTWESTERN URANIUM & VANADIUM CORP - 1 YEAR AGREEMENT INCLUDES DELIVERY OF UP TO 25,000 SHORT TONS OF URANIUM BEARING OREReuters
Mon, Apr 14
Other
Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (Rmat) Designation From FDA For Ft819 To Treat Moderate To Severe Systemic Lupus Erythematosus (Sle)
April 14 (Reuters) - Fate Therapeutics Inc FATE.O:FATE THERAPEUTICS RECEIVES REGENERATIVE MEDICINE ADVANCED THERAPY (RMAT) DESIGNATION FROM FDA FOR FT819 TO TREAT MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)Reuters
Mon, Apr 14
